SK bioscience

Balance sheet - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4th period(2021.12.31) , 5th period(2021.12.31)
Sort	1st period (2018.07.01-2018.12.31)	2nd period (2019.01.01-2019.12.31)	3rd period (2020.01.01-2020.12.31)	4th period (2021.01.01-2021.12.31)	5th period (2022.01.01-2022.12.31)
Liquid assets	180,729	170,741	333,902	1,837,804	1,783,694
Cash and cash equivalents	4,489	14,380	24,972	98,028	225,287
Short-term financial investment	99,189	80,088	183,736	1,547,635	1,255,518
Receivables	43,472	32,429	45,838	48,134	89,661
Inventory assets	31,876	36,379	70,275	135,045	187,406
Other inventory assets	1,650	7,465	782	8,508	16,184
Contract asset	0	0	980	0	0
Derivative financial assets	53	0	128	451	9,638
Non-current assets	219,268	233,239	228,330	272,318	358,237
Long-term financial investment	10,985	10,597	0	21,609	1,500
Deposit	356	348	455	690	3,645
Tangible assets	172,831	182,477	180,992	210,264	264,158
Copy right assets	0	8,293	8,487	10,718	28,899
Intangible assets	21,839	19,479	17,858	17,061	18,181
Other liquid assets	85	85	95	91	6,529
Defined benefit assets	0	0	0	0	13,955
Derivative financial assets	0	65	0	1,639	0
Deferred tax asset	13,172	11,895	20,443	10,241	21,370
Total	399,997	403,980	562,232	2,110,123	2,141,931

Liabilities - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4th period(2021.12.31), 5th period(2022.12.31)
Sort	1st period (2018.07.01-2018.12.31)	2nd period (2019.01.01-2019.12.31)	3rd period (2020.01.01-2020.12.31)	4th period (2021.01.01-2021.12.31)	5th period (2022.01.01-2022.12.31)
Liquid liabilities	50,610	45,509	180,640	459,952	380,037
Purchased and other liabilities	25,542	31,613	39,153	102,184	55,705
Derivative financial liabilities	0	0	75	894	67
Short-term borrowings	0	0	0	0	45,550
Liquidity bond	0	0	10,995	47,977	38,008
Long-term liquidity loan	11,250	0	0	11,671	0
Liquidity lease	161	1,351	1,614	2,309	12,235
Liquidity provision liability	0	0	0	0	2,811
Other liquidity bond	8,374	7,780	28,640	94,638	49,769
Liquidity contract liabilities	5,283	4,687	94,899	98,789	155,676
Corporate tax liabilities (Current period)	0	78	5,264	101,485	20,216
Non-current liabilities	130,142	125,737	117,802	48,858	20,192
Private bonds	92,196	93,473	80,473	35,502	0
Long-term loans	34,353	23,156	21,760	0	0
Lease	0	7,093	7,126	8,774	17,543
Provision liability	0	0	0	0	2,278
Defined-benefit liabilities	1,774	2,015	4,358	4,246	0
Derivative financial liabilities	1,819	0	3,617	0	0
Other non-current liabilities	0	0	468	335	371
Total	180,752	171,246	298,442	508,811	400,229

Capital - Sort, 1st period(2018.12.31), 2nd period(2019.12.31), 3rd period(2020.12.31), 4th period(2021.12.31), 5th period(2022.12.31)
Sort	1st period (2018.07.01-2018.12.31)	2nd period (2019.01.01-2019.12.31)	3rd period (2020.01.01-2020.12.31)	4th period (2021.01.01-2021.12.31)	5th period (2022.01.01-2022.12.31)
Gross capital	10,200	10,200	30,600	38,250	38,392
Capital surplus	201,219	201,219	180,518	1,157,063	1,160,008
Other capital	25	325	901	900	9,848
Accumulated income	(1,242)	(1,319)	-1,465	(207)	77
Retained earnings	9,043	22,309	53,236	405,305	533,377
Total	219,245	232,734	263,790	1,601,311	1,741,702

Income statement - Sort, 1st period(2018.07.01-2018.12.31), 2nd period(2019.01.01-2019.12.31), 3rd period(2020.01.01-2020.12.31), 4th period(2021.01.01-2021.12.31), 5th period(2022.01.01-2022.12.31)
Sort	1st period (2018.07.01-2018.12.31)	2nd period (2019.01.01-2019.12.31)	3rd period (2020.01.01-2020.12.31)	4th period (2021.01.01-2021.12.31)	5th period (2022.01.01-2022.12.31)
Sales profits	99,403	183,938	225,611	929,001	456,726
Sales costs	48,958	106,078	130,269	358,718	217,115
Sales total	50,445	77,860	95,342	570,283	239,611
Sales & maintenance costs	24,009	55,063	57,632	96,063	124,597
Profits	26,436	22,797	37,710	474,220	115,014
Other profits	99	144	3,742	5,159	1,702
Other expenses	12,937	1,934	1,909	2,849	6,148
Financial revenues	1,303	5,184	7,903	26,241	116,609
Financial expenses	2,807	7,706	10,153	31,643	85,443
Net income (Including corporate tax)	12,094	18,485	37,293	471,128	141,733
Corporate tax	3,161	3,808	4,403	115,989	19,281
Net income (Current period)	8,933	14,677	32,890	355,139	122,452
Other comprehensive income	(173)	(1,489)	-2,108	(1,813)	5,905
Other comprehensive income (that is subsequently reclassified as profit or loss)	0	0	0	0	0
Derivative revenues	(283)	(77)	-146	1,257	473
Gain (loss) on overseas business translation	0	0	0	0	(188)
Other comprehensive income (that is subsequently unclassified as profit or loss)	0	0	0	0	0
Remeasurement of defined expenses	110	(1,412)	-1,962	(3,070)	5,620
Accumulated other comprehensive income	8,760	13,188	30,782	353,326	128,357
Basic profits / shares	149	240	537	4,844	1,596
Diluted EPS	0	0	533	4,810	1,590

IR